Agilent Technologies Inc (MIL:1A)

€ 122.18 0 (0%) Market Cap: 36.21 Bil Enterprise Value: 37.26 Bil PE Ratio: 28.59 PB Ratio: 6.71 GF Score: 96/100

Q3 2024 Agilent Technologies Inc Earnings Call Transcript

Aug 21, 2024 / 08:30PM GMT

Release Date Price: €122.18

Transcript 10-Q8-K

Key Points

Positve

Agilent Technologies Inc (A) posted better-than-expected revenue and earnings for Q3 2024.
Earnings per share of $1.32 exceeded the high end of guidance by $0.04.
The company raised its guidance at the midpoint for both revenue and EPS for the full year.
Agilent Technologies Inc (A) announced two strategic acquisitions focused on biopharma and digital ecosystem enhancement.
The Agilent CrossLab Group delivered a record operating margin of 34%, demonstrating the strength of its recurring-revenue business.

Negative

Revenue of $1.578 billion declined by 4.4% year-over-year.
The Life Sciences and Applied Markets Group reported a 7% decline in revenue.
The Diagnostics and Genomics Group posted an 8% decline in revenue.
China revenue declined by 11%, with quarterly revenue improving only sequentially.
Capital-equipment budgets remained constrained, impacting the instrument side of the business.

Operator

Ladies and gentlemen, welcome to the Agilent Technologies Q3 2024 earnings call. My name is Regina, and I will be coordinating your call today. (Operator Instructions). I will now hand you over to your host Parmeet Ahuja, to begin. Please go ahead.

Parmeet Ahuja

Agilent Technologies Inc - Investor Relation

Thank you, and welcome everyone to Agilent's conference call for the third quarter of fiscal year 2024. With me are Padraig McDonnell, Agilent president and CEO, and Bob McMahon, Agilent senior vice president and CFO.

Joining in the Q&A will be Phil Binns, president of the Agilent Life Sciences and Applied Markets Group; Simon May, president of the Agilent Diagnostics and Genomics Group; and Angelica Riemann, president of the Agilent CrossLab Group.

This presentation is being webcast live. The news release for our third-quarter financial results, investor presentation, and information to supplement todayâs discussion, along with a recording of this webcast are available on our website at

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.